Medical News Today: New drug shows promise against several aggressive cancers

A new phase I/II open-label, dose-escalation trial has recently tested the effectiveness of a “Trojan horse” drug in treating multiple types of otherwise treatment-resistant cancer in its late stages. A new clinical trial assesses the safety and effectiveness of an innovative drug against multiple cancers at an advanced stage. Recently, a team of experts from… Read More »

Why too much DNA repair can injure tissue

DNA-repair enzymes help cells survive damage to their genomes, which arises as a normal byproduct of cell activity and can also be caused by environmental toxins. However, in certain situations, DNA repair can become harmful to cells, provoking an inflammatory response that produces severe tissue damage. MIT Professor Leona Samson has now determined that inflammation… Read More »